ATCC and Broad Institute Engineer New Cancer Models to Decode Resistance to Targeted Therapy
ATCC and the Broad Institute collaborated to develop CRISPR-engineered drug-resistant isogenic cell lines that replicate clinically observed resistance mechanisms to targeted therapies.
ATCC Awarded Funding for USDA HPAI Poultry Innovation Grand Challenge
ATCC awarded USDA funding to advance poultry biosecurity and pandemic preparedness through high‑quality reference materials for highly pathogenic avian influenza.
ATCC Receives New CDC Award to Help Fast-track Diagnostic Tests for Future Disease Outbreaks
ATCC secures a new CDC award to fast‑track scalable diagnostic tests and strengthen U.S. preparedness for future disease outbreaks.
ATCC Secures NIAID Contract to Strengthen U.S. Preparedness Against Emerging Infectious Diseases
ATCC expands its partnership with NIAID, advancing U.S. readiness against emerging infectious diseases through enhanced testing and assay development.
ATCC Expands Role in Supporting the NIST's Monoclonal Antibody Reference Materials
ATCC expands its collaboration with NIST to deliver trusted monoclonal antibody reference materials that strengthen reproducibility and accelerate therapeutic innovation.
